Drug Sponsors

Warnex completes sale of bioanalytical services to CRO Biotrial

Monday, December 17, 2012 11:06 AM

Warnex, a life sciences company, has successfully completed the sale of its bioanalytical services division to Biotrial Research, a privately-owned CRO headquartered in France.

More... »

Fresenius to discontinue biotech subsidiary

Friday, December 14, 2012 01:27 PM

Fresenius, a health care group with international operations, has decided to discontinue its subsidiary Fresenius Biotech. Instead, the company will focus on its four established business segments Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed, which offer significant growth opportunities.

More... »

Biocartis completes $44.5M series D funding

Friday, December 14, 2012 11:12 AM

Biocartis, a molecular diagnostics company developing and commercializing high quality, easy to use platforms and clinically relevant oncology assays, has completed a $44.5 million Series D equity funding entirely backed by existing investors.

More... »

The Medicines Company to acquire Incline Therapeutics

Friday, December 14, 2012 10:14 AM

The Medicines Company, a medical solutions company based in Parsippany, N.J., has agreed to acquire Incline Therapeutics, hospital-focused specialty pharmaceutical company based in Redwood City, Calif.

More... »

Galderma to acquire Spirig Pharma

Wednesday, December 12, 2012 02:31 PM

Galderma Pharma, a Switzerland-based global specialty pharmaceutical company focused on dermatology, has entered into a definitive agreement to acquire Spirig Pharma, a Swiss company that develops, produces, and markets dermatological products.

More... »

Roche to invest $258M in diagnostics production in Germany

Wednesday, December 12, 2012 02:02 PM

Switzerland-based Roche has announced plans to invest over $258 million in its Penzberg biotechnology center, near Munich, Germany.

More... »

Gilead Sciences to acquire YM Biosciences

Wednesday, December 12, 2012 11:17 AM

Gilead Sciences, a biopharmaceutical company based in Foster City, Calif., has signed a definitive agreement to acquire YM BioSciences, a drug development company based in Canada, for $2.95 per share in cash. 

More... »

Pernix Therapeutics to acquire Somaxon Pharmaceuticals

Wednesday, December 12, 2012 09:22 AM

Pernix Therapeutics, a specialty pharmaceutical company based in The Woodlands, Texas, has entered into a definitive merger agreement to acquire Somaxon Pharmaceuticals, a San Diego-based specialty pharmaceutical company, in a stock-for-stock transaction with a total equity value of $25 million.

More... »

Amgen to acquire deCODE Genetics

Monday, December 10, 2012 09:40 AM

Amgen, a biotech based in Thousand Oaks, Calif., has entered into a definitive agreement to acquire deCODE Genetics, an Iceland-based company that analyzes the human genome.

More... »

UAE, Merck Serono, Neopharma form first pharmaceutical production agreement

Wednesday, December 5, 2012 11:35 AM

Merck Serono, a division of Germany-based Merck, and a local manufacturer, Neopharma, have formed the first partnership of its kind to locally produce Merck branded medication in the UAE for distribution across the Middle East.

More... »